Helvetia Pharma

Helvetia Pharma is committed to a cost-effective development of pharmaceuticals focusing primarily on niche indications and oncology, immunosuppression and urology. We seek to accelerate product development and marketing by in-licensing pharmaceuticals.
We are looking for partners interested in in-licensing their products in CEE countries and in mutual cooperation.

Activity:

- Clinical Trials
- Contract Manufacturing
- Contract Research
- Licensing & Business Development
- Regulatory Affairs & Legal Services
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- Generics
- FP (finished products)
- Pharmaceuticals / Therapeutics
- Nutritionals / Vitamins
- Prescription drugs (Rx)

Therapeutic targets:

- Cancer
- Dermatology
- Oncology
- Transplant

Markets Covered

a. HeadQuarter: Czech Republic

b. Continent(s) active: Europe

c. Countries active: Czech Republic, Slovak Republic

Corporate data:

Number of Employees: 20

Turnover:

Amount:	Year:	Currency:
1	2005	Euro

Year founded: 2005